MAPT and Alzheimer disease: Therefore, it is exceedingly difficult to diagnose AD early enough to prevent progression of the disease when the irreversible molecular hallmarks of brain pathology, i.e., the aggregation of amyloid beta (Aβ) plaques and neurofibrillary Tau tangles, have become pronounced.